首页> 外文期刊>Oriental Journal of Chemistry: An International Research Journal of Pure & Applied Chemistry >Determination of Doxazosin mesylate by Ion-pair Complex Formation with Bismuth (III) Tetraiodide Using Spectrophotometric and Atomic Absorption Spectroscopic
【24h】

Determination of Doxazosin mesylate by Ion-pair Complex Formation with Bismuth (III) Tetraiodide Using Spectrophotometric and Atomic Absorption Spectroscopic

机译:分光光度法和原子吸收光谱法测定四碘化铋(Ⅲ)离子对络合物的甲磺酸多沙唑嗪含量。

获取原文
获取原文并翻译 | 示例
           

摘要

Two simple, sensitive spectroscopic and atomic absorption spectrometric (AAS) methods have been suggested for the determination of doxazosinmesylate in pure form and tablet formulations. The methods are based on the formation of ion-pair associate between the drug and the inorganic complex, bismuth(III) tetraiodide. The reaction occurs in nitric acid medium forming orange-reda ion-pair associate which is instantaneously precipitated. The formed precipitate is filtered off and the residual unreacted metal complex in the filtrate is determined either spectrophotometrically at 453 nm or by AAS at 223.1 nm. Also, the precipitatemay be dissolved in acetone and quantified spectrophotometically at 470nm or decomposed by hydrochloric acid, and the bismuth content is determined by AAS at 223.1 nm.The two methods permit the determination of doxoazosinmesylate in the range of 5-80ug L~(-1). The proposed methods were successfully applied to determine doxazosinmesylate in its tablet formulations without any evidence for interference from pharmaceutical additives. The results were in good agreement with those obtained the reference method. The proposed methods, especially if automated, can be confidently applied for quality control and routine analysis of doxazosinmesylate.
机译:已经提出了两种简单,灵敏的光谱学和原子吸收光谱法(AAS)测定纯形式和片剂中的多沙唑亚甲磺酸酯。该方法基于药物与无机配合物四碘化铋(III)之间离子对缔合的形成。该反应在硝酸介质中发生,形成橙色-reda离子对缔合物,该缔合物瞬间沉淀。滤出形成的沉淀物,并通过分光光度法在453nm下或通过AAS在223.1nm下测定滤液中残留的未反应的金属络合物。同样,沉淀物可以溶解在丙酮中,并在470nm处分光光度法定量或由盐酸分解,并通过AAS在223.1nm处测定铋含量。两种方法均可测定5-80ug L〜(- 1)。所提出的方法已成功地用于测定其片剂中的多沙唑肟基甲酸酯,而没有任何药物添加剂干扰的证据。结果与参考方法获得的结果吻合良好。所提出的方法,尤其是自动化方法,可以放心地用于多沙唑肟基甲酸酯的质量控制和常规分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号